February 04, 2022
A Delaware federal judge has ordered Belcher Pharmaceuticals to foot the bill for Pfizer unit Hospira in Belcher's patent infringement suit over epinephrine injector Abboject, finding that the accuser's antics during the litigation — and the "weak" suit it lodged — called for the company to cover Hospira's fees.
April 01, 2020
Belcher Pharmaceuticals LLC's attempt to hold a Pfizer Inc. unit responsible for patent infringement with its new epinephrine injector Abboject failed this week, when U.S. District Judge Leonard P. Stark instead invalidated the company's patent following a bench trial.